Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1753-4887.1996.tb03835.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.
NPJ Breast Cancer
January 2025
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Endocrine therapy with CDK4/6 inhibitors is standard for estrogen receptor-positive, HER2-negative metastatic breast cancer (ER+/HER2- MBC), yet clinical resistance develops. Previously, we demonstrated that low doses of palbociclib activate autophagy, reversing initial G1 cell cycle arrest, while high concentrations induce off-target senescence. The autophagy inhibitor hydroxychloroquine (HCQ) induced on-target senescence at lower palbociclib doses.
View Article and Find Full Text PDFSafety, tolerability and therapeutic efficacy of anti-inflammatory drug pirfenidone in acute pancreatitis patients: Protocol for a randomized pilot clinical trial.
Pancreatology
January 2025
Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA; Veterans Affairs Medical Center, Birmingham, AL, USA. Electronic address:
Background: Acute Pancreatitis (AP) is a formidable disease with significant morbidity, mortality and healthcare expenditure. There is an emergent need to develop therapeutic agents for this disease as there are no targeted therapies available. We have recently demonstrated that pirfenidone can significantly decrease the severity of AP in animal models.
View Article and Find Full Text PDFSolid waste management and resource recovery during the 4-crew 180-day CELSS integrated experiment.
Life Sci Space Res (Amst)
February 2025
China Astronaut Research and Training center, Beijing 100094, PR China.
In order to explore the management and treatment methods of solid waste in the Controlled Ecological Life Support System (CELSS) of future lunar bases, during the 4-crew 180-day integrated experiment, the Solid Waste Management and Treatment System (SWMTS) was built, in which the treatment of recyclable solid waste such as inedible plant parts and human excrement was completed through a combination of biological aerobic composting and high-temperature oxidation. Basic data on the types and amounts of solid waste generated during the 4-crew 180-day experiment mission were obtained. There were six types of solid wastes, including the work support wastes, the household support wastes, the plant cultivation wastes, the plant-based wastes, and crew feces.
View Article and Find Full Text PDFPublic Understanding and Expectations of Digital Health Evidence Generation: Focus Group Study.
JMIR Form Res
January 2025
Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, United Kingdom, 44 07742966769.
Background: The rapid proliferation of health apps has not been matched by a comparable growth in scientific evaluations of their effectiveness, particularly for apps available to the public. This gap has prompted ongoing debate about the types of evidence necessary to validate health apps, especially as the perceived risk level varies from wellness tools to diagnostic aids. The perspectives of the general public, who are direct stakeholders, are notably underrepresented in discussions on digital health evidence generation.
View Article and Find Full Text PDFHuman organotypic colon in vitro microtissue: unveiling a new window into colonic drug disposition.
Eur J Pharm Sci
January 2025
Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address:
The purpose of this study was to evaluate EpiColon, a novel human organotypic 3D colon microtissue prototype, developed to assess colonic drug disposition, with a particular focus on permeability ranking, and compare its performance to Caco-2 monolayers. EpiColon was characterized for barrier function using transepithelial electrical resistance (TEER), morphology via histology and immunohistochemistry, and functionality through drug transport studies measuring apparent permeability (P). Cutoff thresholds for the permeability of FITC-dextran 4 kDa (FD4), FITC-dextran 10 kDa (FD10S), and [C]mannitol were established to monitor microtissue integrity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!